Content about Pittsburgh

December 2, 2013

Vaccines have prevented an estimated 100 million cases of serious childhood contagious diseases in the nearly 90 years since the vaccine for pertussis, or whooping cough, became available, according to a new study.

PITTSBURGH — Vaccines have prevented an estimated 100 million cases of serious childhood contagious diseases in the nearly 90 years since the vaccine for pertussis, or whooping cough, became available, according to a new study.

November 18, 2013

Generic drug maker Mylan has launched its version of a drug for treating attention deficit hyperactivity disorder, the company said Monday.

PITTSBURGH — Generic drug maker Mylan has launched its version of a drug for treating attention deficit hyperactivity disorder, the company said Monday.

Mylan announced the launch of dexmethylphenidate hydrochloride extended-release capsules in the 30-mg strength, a generic version of Novartis' Focalin XR. As the first company to win approval for a generic version of the drug, Mylan has 180 days in which to compete exclusively against Novartis' product.

November 13, 2013

During the past five football seasons, Head & Shoulders, the official shampoo of the National Football League, has gone to great lengths to celebrate "Mane Man" Troy Polamalu's legendary locks, from insuring his hair for $1 million to immortalizing it in wax. After growing his infamous mane for more than 11 years and using Head & Shoulders along the way, Polamalu participated in a ceremonial haircut Tuesday during The “VFW Mane Event” at Heinz Field in Pittsburgh.

CINCINNATI — During the past five football seasons, Head & Shoulders, the official shampoo of the National Football League, has gone to great lengths to celebrate "Mane Man" Troy Polamalu's legendary locks, from insuring his hair for $1 million to immortalizing it in wax. After growing his infamous mane for more than 11 years and using Head & Shoulders along the way, Polamalu participated in a ceremonial haircut Tuesday during The “VFW Mane Event” at Heinz Field in Pittsburgh.

November 11, 2013

Mylan has launched its generic version of a drug used to treat gastroesophageal reflux disease, the U.S.-based generic drug maker said Monday.

PITTSBURGH — Mylan has launched its generic version of a drug used to treat gastroesophageal reflux disease, the U.S.-based generic drug maker said Monday.

Mylan announced the launch of rabeprazole sodium extended-release tablets in the 20-mg strength, a generic version of Eisai's Aciphex. The Food and Drug Administration approved generic versions of Aciphex made by six companies on Friday.

Aciphex had sales of about $830.1 million during the 12-month period that ended in September, according to IMS Health. 

November 1, 2013

Mylan expects to be the first to market with a generic version of a drug for treating patients with gout, the company said Friday, though its filing has triggered a lawsuit from the makers of the branded version.

PITTSBURGH — Mylan expects to be the first to market with a generic version of a drug for treating patients with gout, the company said Friday, though its filing has triggered a lawsuit from the makers of the branded version.

November 1, 2013

Nikki’s Magic Wand, which enables consumers to access that remaining 20% of concealer, lip gloss or mascara that otherwise remains unused at the bottom of the tube, has announced that it is launching its first mass market campaign in time for the holiday season.

PITTSBURGH — Nikki’s Magic Wand, which enables consumers to access that remaining 20% of concealer, lip gloss or mascara that otherwise remains unused at the bottom of the tube, has announced that it is launching its first mass market campaign in time for the holiday season.

October 31, 2013

Mylan experienced a slight dip in sales in its third quarter, due primarily to fluctuating currency values, the generic drug maker said Thursday.

PITTSBURGH — Mylan experienced a slight dip in sales in its third quarter, due primarily to fluctuating currency values, the generic drug maker said Thursday.

October 17, 2013

Generic drug maker Mylan has appointed Jacek Glinka as president of its European division, the company said Thursday.

PITTSBURGH — Generic drug maker Mylan has appointed Jacek Glinka as president of its European division, the company said Thursday.

Glinka's appointment becomes effective Dec. 2. Before joining Mylan, he was CEO of Polpharma Group from 2003 to 2006 and again from 2009 until this year, helping the company expand from a small, local company to a leading drug company in central and eastern Europe, the Caucasus and Central Asia. The company became a leader in the Polish market and doubled its sales to more than $1 billion between 2011 and 2013.

October 3, 2013

GNC Holdings on Wednesday announced it has acquired A1 Sports Limited (d.b.a. Discount Supplements), a multi-brand sports nutrition e-commerce retailer in the United Kingdom.

PITTSBURGH — GNC Holdings on Wednesday announced it has acquired A1 Sports Limited (d.b.a. Discount Supplements), a multi-brand sports nutrition e-commerce retailer in the United Kingdom. 

The acquisition was funded with cash on hand. Terms of the deal were not disclosed.

Following the acquisition, GNC.com, LuckyVitamin.com and discount-supplements.co.uk will continue to operate as separate businesses, each with its own product offerings and target customers.

September 30, 2013

Mylan has launched the first generic version of a drug used to treat fungal infections, the company said Monday.

PITTSBURGH — Mylan has launched the first generic version of a drug used to treat fungal infections, the company said Monday.

The drug maker announced the launch of voriconazole for oral suspension in the 40-mg-per-mL strength. The drug is the first generic version of Pfizer's Vfend, and as the first company to receive approval for a generic version, Mylan has 180 days in which to compete exclusively against Pfizer's product. The drug is used to treat invasive fungal infections.

September 27, 2013

Celebrity Chef Robert Irvine, along with nutritional products brand FortiFX, is pleased to announce the debut of a new line of six-layer baked meal-replacement bars — Fit Crunch Baked Bars — which are high in protein and low in sugar without compromising taste and texture.

PITTSBURGH — Celebrity Chef Robert Irvine, along with nutritional products brand FortiFX, is pleased to announce the debut of a new line of six-layer baked meal-replacement bars — Fit Crunch Baked Bars — which are high in protein and low in sugar without compromising taste and texture.

September 25, 2013

Mylan is challenging the patent protection on a drug used to treat fibromyalgia, prompting a lawsuit from the branded drug's manufacturers.

PITTSBURGH — Mylan is challenging the patent protection on a drug used to treat fibromyalgia, prompting a lawsuit from the branded drug's manufacturers.

Mylan said Wednesday that Forest Labs and Royalty Pharma had sued it in the U.S. District Court for the District of Delaware in connection with its filing of a regulatory approval application with the Food and Drug Administration for milnacipran hydrochloride tablets in the 12.5-mg, 25-mg, 50-mg and 100-mg strengths. The drug is a generic version of Savella.

September 3, 2013

Indian regulators have approved a deal from Mylan to buy the injectables business of Strides Arcolab, Mylan said Tuesday.

PITTSBURGH — Indian regulators have approved a deal from Mylan to buy the injectables business of Strides Arcolab, Mylan said Tuesday.

Following the approval of Agila by India's Foreign Investment Promotion Board, Mylan also received approval from the Cabinet Committee on Economic Affairs. The deal is expected to close in fourth quarter 2013. Mylan announced its plan to buy Agila for $1.6 billion in February 2013.

August 28, 2013

A consumer group is urging the Pennsylvania state legislature to increase access to vaccines for children and teenagers.

PITTSBURGH — A consumer group is urging the Pennsylvania state legislature to increase access to vaccines for children and teenagers.

Pharmacy Choice and Access Now said Wednesday it was encouraging the Pennsylvania General Assembly to support House Bill 776, which would pharmacists to help increase immunization rates among children ages 7 years and older, with parental consent. The bill, sponsored by Republican state Rep. Seth Grove, has received support from educators, healthcare professionals and students.

August 22, 2013

The Food and Drug Administration has approved a supplemental regulatory application from Mylan for a generic antidepressant that was subject last year to scrutiny by the agency amid reports of efficacy problems, Mylan said Thursday.

PITTSBURGH — The Food and Drug Administration has approved a supplemental regulatory application from Mylan for a generic antidepressant that was subject last year to scrutiny by the agency amid reports of efficacy problems, Mylan said Thursday.

The drug maker announced the approval of its supplemental abbreviated new drug application, or sANDA, for bupropion hydrochloride extended-release tablets in the 300-mg strength. The drug is a generic version of GlaxoSmithKline's Wellbutrin XL.

August 21, 2013

Clif Bar announced the two winners of the "Feed Your Strength ... At Work!" contest — Yurbuds, a St. Louis-based company that makes custom fit, high-end earphones; and 4Moms a company dedicated to making innovative baby products located in Pittsburgh.

EMERYVILLE, Calif. — Clif Bar on Tuesday announced the two winners of the "Feed Your Strength ... At Work!" contest — Yurbuds, a St. Louis-based company that makes custom fit, high-end earphones; and 4Moms a company dedicated to making innovative baby products located in Pittsburgh. 

As the two grand prize winners, each company will receive a Luna vending machine filled with complimentary Luna bars and will get the chance to participate in six nutrition consultation sessions led by the Luna brand's nutrition team.

August 6, 2013

GNC Holdings concluded its Total Lean Challenge and Sweepstakes, rewarding 13 participants with a share of $25,000 in cash and prizes.

PITTSBURGH — GNC Holdings on Tuesday concluded its Total Lean Challenge and Sweepstakes, rewarding 13 participants with a share of $25,000 in cash and prizes. 

The grand prize winner Karen Parra of Sacramento, Calif. received $10,000, and 12 other lucky sweepstakes participants each received $1,250 in prizes as part of a 12-week challenge designed to help consumers transform their eating and exercise habits for long-term weight management by giving them a practical way to take control of their health.

August 6, 2013

Mylan's sales ticked up slightly in second quarter 2013, compared with the same period last year, the company said.

PITTSBURGH — Mylan's sales ticked up slightly in second quarter 2013, compared with the same period last year, the company said.

The Pittsburgh-based generic drug maker reported sales of $1.7 billion, a 1% increase over second quarter 2012's $1.69 billion. For the six-month period that ended June 30, sales were $3.33 billion, a 2% increase over $3.27 billion during the same period last year.

July 30, 2013

GNC on Monday named Carmine Fortino EVP business development. Fortino comes to GNC from Atrium Innovations, a Canadian natural health products company, where he was president. Fortino also was a former director of GNC from 2007 to 2011.

PITTSBURGH — GNC on Monday named Carmine Fortino EVP business development. Fortino comes to GNC from Atrium Innovations, a Canadian natural health products company, where he was president. Fortino also was a former director of GNC from 2007 to 2011.

"[Carmine's] background in multi-channel development across the health & wellness segment will enhance our approach to new market opportunities as we continue to implement GNC's proven growth strategy," stated Joseph Fortunato, GNC's chairman, president and CEO.

July 25, 2013

Mylan and Orion Corp. have settled a patent-infringement suit over a drug used to treat Parkinson's disease.

PITTSBURGH — Mylan and Orion Corp. have settled a patent-infringement suit over a drug used to treat Parkinson's disease, Mylan said Thursday.

The generic drug maker had filed with the Food and Drug Administration for a generic version of Orion's Stalevo (carpidopa; levodopa; entacapone) tablets, used to treat idiopathic Parkinson's to substitute for immediate-release carbidopa/levodopa and entacapone administered separately.

July 24, 2013

Mylan has settled with the makers of a drug used to treat cancer in a patent-infringement lawsuit, the generic drug maker said.

PITTSBURGH — Mylan has settled with the makers of a drug used to treat cancer in a patent-infringement lawsuit, the generic drug maker said Wednesday.

Mylan said it had entered an agreement with Pfizer, Genentech and OSI that would allow their suit against Mylan over the drug Tarceva (erlotinib) to be dismissed. All other terms and conditions of the settlement are confidential, and the agreement is subject to Department of Justice and Federal Trade Commission review, Mylan said.

July 23, 2013

A federal court has ruled that a Mylan lawsuit against GlaxoSmithKline over an antidepressant drug can go to trial.

PITTSBURGH — A federal court has ruled that a Mylan lawsuit against GlaxoSmithKline over an antidepressant drug can go to trial, Mylan said Tuesday.

Mylan alleges that GlaxoSmithKline breached a contract the two companies had made when it agreed to supply competing drug maker Apotex with paroxetine hydrochloride extended-release tablets, a generic version of Paxil CR. The Third Circuit Court of Appeals' ruling reversed a summary judgment dismissing Mylan's claim.

July 22, 2013

The Eastern retail landscape will continue to host the latest in Western ideas of wellness as GNC announced its expansion into the Chinese marketplace with the first stand-alone GNC store in Shanghai.

PITTSBURGH — The Eastern retail landscape will continue to host the latest in Western ideas of wellness as GNC on Monday announced its expansion into the Chinese marketplace with the first stand-alone GNC store in Shanghai. The move complements GNC's existing marketing footprint in China.  

July 17, 2013

A federal court in New York has dismissed a lawsuit alleging that Mylan infringed four of Teva Pharmaceutical Industries' patents when it sought Food and Drug Administration approval for a multiple sclerosis drug.

PITTSBURGH — A federal court in New York has dismissed a lawsuit alleging that Mylan infringed four of Teva Pharmaceutical Industries' patents when it sought Food and Drug Administration approval for a multiple sclerosis drug.

Mylan had filed with the FDA for approval of a generic version of Teva's Copaxone (glatiramer acetate), attracting a patent-infringement suit from Teva alleging that it violated four patents on the drug, according to FDA records. The U.S. District Court for the Southern District of New York has dismissed the case.

July 16, 2013

Mylan has launched a generic contraceptive therapy, the drug maker said Tuesday.

PITTSBURGH — Mylan has launched a generic contraceptive therapy, the drug maker said Tuesday.

Mylan, through its Mylan Pharmaceuticals subsidiary, announced the launch of norethindrone tablets in the 0.35-mg strength. The drug is a generic version of Actavis' Nor-Q.D. tablets, which are taken on a 28-day cycle to prevent pregnancy. Mylan is partnering with Famy Care, which filed for and received Food and Drug Administration approval for the drug.